MELISSA MCCAFFREY: Open Payments
NPI 1760018097 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,123 in 96 payments from 26 companies in 2025. Trend: 2023 $986 · 2024 $714 · 2025 $2,123
Food & beverage: $2,123
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $303 |
| Phathom Pharmaceuticals, Inc. | 8 | $267 |
| AstraZeneca Pharmaceuticals LP | 11 | $225 |
| Lilly USA, LLC | 14 | $221 |
| Axsome Therapeutics, Inc. | 6 | $206 |
| PFIZER INC. | 5 | $134 |
| Sumitomo Pharma America, Inc. | 4 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Exact Sciences Corporation | 3 | $78 |
Products named: VOQUEZNA, Auvelity, Ozempic, JARDIANCE, MOUNJARO, AIRSUPRA, Wegovy, GEMTESA.
Industry payments across NY — which companies pay providers there.
